Poslední aktualizace :
08/05/2024
Antibiotikas   Ceftazidime Avibactam  
Įpurškimas
Tirpalų stabilumas Mišinių stabilumas Stabilumą lemiantys veiksniai Suderinamumas Leidimo būdai Bibliografija Pdf
   Cheminė sandara  

Prekinis pavadinimas   Prekinis pavadinimas     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Avycaz Jungtinės Amerikos Valstijos
Torgena Brazilija
Zavicefta Airija, Argentina, Australija, Belgija, Čilė, Didžioji Britanija, Ispanija, Italija, Jungtinės Amerikos Valstijos, Liuksemburgas, Meksikas, Norvegija, Peru, Prancūzija, Rumunija, Slovėnija, Suomija, Švedija, Šveicarija, Tunisas, Vengrija, Vokietija
Bibliografija   Įpurškimas   Bibliografija : Ceftazidime Avibactam  
Tipas Leidinys
2902 Laboratorija Ceftazidime - avibactam (Avycaz®) - Summary of Product Characteristics
Forrest Pharmaceuticals 2015
3520 Laboratorija Cidomycin - Summary of product Chracteristics.
Sanofi 2011
3549 Laboratorija Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3643 Laboratorija Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
3674 Laboratorija Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3984 Žurnalas Meyer K, Santarossa M, Danziger L.H, Wenzler E.
Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water.
Hosp Pharm 2017 ,52;3 : 221-228
4055 Žurnalas Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 , 75, 1:36-44
4145 Žurnalas Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P.
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4434 Žurnalas Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L.
Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
Clin Ther 2019 ; 41, 10: 2162-2170.
4528 Žurnalas Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Int J Pharm Compound 2021 ;25,1:52-61
4548 Žurnalas O'Donnell J.N, Xu A, Lodise T.P.
Intravenous Compatibility of Ceftazidime/Avibactam and Aztreonam Using Simulated and Actual Y-site Administration.
Clin Ther 2020 ; 42, 8: 1580-1586.
4634 Žurnalas Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A.
Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy.
Antibiotics 2022 ;11,4: 458
4801 Žurnalas Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J.
Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2024 ;51,1:

  Mentions Légales